U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Dodwell Co Inc - 491381 - 04/20/2020
  1. Warning Letters

CLOSEOUT LETTER

Dodwell Co Inc MARCS-CMS 491381 —

Product:
Food & Beverages
Recipient:
Recipient Name
Kevin K. Lau
Recipient Title
Co-Owner
Dodwell Co Inc

435 4th St.
Oakland, CA 94607
United States

Issuing Office:
Office of Human and Animal Food Operations West Division 5

1201 Harbor Bay Parkway
Alameda, CA 94502
United States

Dear Mr. Lau:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter March 4, 2016. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Sergio Chavez, Compliance Branch Director
Office of Human and Animal Food Operations
West Division 5

Back to Top